Hutchison China Meditech Ltd. - ADR

NASDAQ:HCM 3:59:48 PM EDT

27.86

-2.15 (-7.16%)

Market Cap (Intraday)	3.76B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$56.32 Million
Adjusted EPS	-$0.18

See more estimates

10-Day MA	$29.92
50-Day MA	$32.90
200-Day MA	$30.36

See more pivots

Hutchison China MediTech Ltd. Stock, NASDAQ:HCM

Cheung Kong Center, 2 Queen's Road Central, Hong Kong, Central & Western

Cayman Islands

Phone: +852.2128.8200

Number of Employees: 853

http://www.chi-med.com

Description

Hutchison China MediTech Ltd. is a holding company, which engages in the research and development, manufactures, and sells pharmaceuticals and health oriented consumer products. It operates through the Innovation Platform and Commercial Platform segments. The Innovation Platform segment relates to research and development of innovative therapeutics in oncology and autoimmune diseases. The Commercial Platform segment relates to prescription drugs which develops, manufacture, markets, and sale of prescription pharmaceuticals; and consumer health which comprised of development, manufacture, distribution, and marketing of over-the-counter pharmaceuticals, and consumer health products. The company was founded in June 2000 and is headquartered in Hong Kong.